John R. Graham | Tuesday December 8, 2015 at 9:49 AM PST
Jeanne Whalen of the Wall Street Journal has written a feature article comparing U.S. prescription drug prices to those overseas. Unsurprisingly, she find prices in other developed countries lower, and credits government price controls in other countries with (pretty much) all the difference. A vial of the cancer drug Rituxan cost Norway’s taxpayer-funded health...
Read More »